期刊
CLINICAL AND EXPERIMENTAL DERMATOLOGY
卷 43, 期 5, 页码 573-576出版社
WILEY
DOI: 10.1111/ced.13408
关键词
-
类别
Omalizumab (Xolair((R))) is an anti-IgE monoclonal antibody, which may benefit adults with systemic mastocytosis. We report effective treatment with omalizumab in two toddlers with severe diffuse cutaneous mastocytosis. Our cases offer preliminary evidence to support the safe use of omalizumab in paediatric patients with cutaneous mastocytosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据